MedTrace Logo

A Study of Dementia and Neurological Problems in HIV Infected Patients Who Are Participating in ACTG A5175

NCT00096824 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 860

Last updated 2015-03-18

No results posted yet for this study

Summary

The purpose of this study is to determine how often dementia and other neurological problems occur in people with HIV. Participants of ACTG A5175 will enroll in this study.

Conditions

  • HIV Infections

Interventions

BEHAVIORAL

Neurological assessment

All participants will undergo neurological examinations and neuropsychological assessments.

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

    lead NETWORK

Principal Investigators

  • Kevin Robertson, PhD · Department of Neurology, University of North Carolina at Chapel Hill

  • Johnstone Kumwenda, MD, MBBS, MMED · Internal Medicine, Johns Hopkins Project

  • Khuanchai Supparatpinyo, MD · Research Institute for Health Sciences, Chiang Mai University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-02-28
Primary Completion
2010-05-31
Completion
2010-05-31

Countries

  • Brazil
  • India
  • Malawi
  • South Africa
  • Zimbabwe

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00096824 on ClinicalTrials.gov